 Drug prophylaxis human immunodeficiency virus-infected pregnant women ethical considerations women human immunodeficiency virus birth United Many women human immunodeficiency virus tests prenatal settings incentives access medications disease-free intervals nonpregnant human immunodeficiency virus-infected individuals use medications pregnancy prenatal use Thus consideration agents clinicians postpartum period article availability agents women seropositive human immunodeficiency virus part informed consent process